Skip to main content

Table 6 Herpes zoster hospitalisation rates, durations and associated healthcare costs in Asia-Pacific countries

From: Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific

Country (source)

Study period

Age profile (years)

Hospitalisations (100000 person years)

Hospitalisation duration (days)

Healthcare costs (US$ equivalent)c

Overall average

Complications

Per patient

Annual total (millions)

 

None

With

Outpatient

Inpatient

 

Taiwan (Lin 2010) [136]

2000–2005

All ages

14.6

8.3

8.0

8.6

  

7.7 in 2000 → 9.8 in 2004 (NT$ 319,000,000)

≥80

105.1

    

204.0

Taiwan (Jih 2009) [137]

2000–2006

All ages

16.1

8.3

  

78.4

1800.3

0.669773 (NT$ 14,147,543)

0–20

 

6.06

    

≥60

59.5% of total

9.19

    

59.5% of total

Korea (Cheong 2014) [96]

2009

≥50 years

88.8d

10.93

 

14.75e

176.0 (161.0–240.0f)

63.2

Australia (Stein 2009) [104]

1998–2005

≥50 years

28.0a

6.8a

6.0

8.6 (5.2–14.6b)

 

3922.2a

27.5

≥80

95.8

      

Thailand (Aunhachoke 2011) [30]

2007–2008

Mean 59

    

90.4 (by 180 days follow-up)

~1.1% per capita income

Korea (Choi WS) [140]

2003–2007

All ages

22.0–32.0

     

75.9 increasing by 14–20% per year to 143.8

Australia (MacIntyre 2003) [102]

1998–1999

Mean 69

25.0

12.7

     

>50

53.0% of total

      

≥80

>150.0

      

Korea (Song 2014) [25]

2009–2010

Mean 64

 

8.9

     

Korea (Kim YJ) [138]

2011

All ages

51.2

      

≥80

266.3

      

Australia (Carville 2010) [147]

2006–2007

All ages

9.1a

      

≥80

89.4a

      

Australia (Araújo 2007) [7]

2000–2002

All ages

10.0a

      

Australia (Heywood 2014) [2]

2006–2010

All ages

10.4

      
  1. aPrincipal diagnosis of herpes zoster
  2. bHerpes zoster encephalitis
  3. cValues not already stated in US$ equivalent, converted at average annual exchange rate in year prior to publication
  4. dBased on prevalence rate of 18.54/1000 persons
  5. ePost-herpetic neuralgia
  6. fSeverely immunocompromised